Improved oral delivery of valsartan from maltodextrin based proniosome powders

Advanced Powder Technology

Volumn 23, Issue 5, 2012, Pages 583-590

  Gurrapu, Alekhya ^a   Jukanti, Raju ^b   Bobbala, Sharan Reddy ^b   Kanuganti, Swetha ^b   Jeevana, Jyothi B ^a  

^a INSTITUTE OF PHARMACEUTICAL TECHNOLOGY   (India)

^b ST PETER'S INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Dissolution; Maltodextrin; Proniosomes; Span 60; Valsartan

Indexed keywords

AMPHIPHILIC DRUGS; CHEMICAL INTERACTIONS; CRYSTALLINE-TO-AMORPHOUS; ENTRAPMENT EFFICIENCY; EQUIMOLAR RATIO; FLOW PROPERTIES; IN-VITRO DISSOLUTION; INTESTINAL FLUID; MALTODEXTRINS; MOLECULAR STATE; NIOSOMES; ORAL DELIVERY; PERMEATION ENHANCEMENT; POWDER X RAY DIFFRACTION; PRONIOSOMES; SOLID-STATE PROPERTIES; SPAN 60; VALSARTAN; VESICLE SIZE;

CHOLESTEROL; DIFFERENTIAL SCANNING CALORIMETRY; DISSOLUTION; LOADING; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

POWDERS;

EID: 84856621706     PISSN: 09218831     EISSN: 15685527     Source Type: Journal    
DOI: 10.1016/j.apt.2011.06.005     Document Type: Article

References (38)

1. Lobenberg, and G.L. Amidon Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards Eur. J. Pharm. Biopharm. 50 2000 3 12
2. B.J. Aungst Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism J. Pharm. Sci. 82 1993 979 986
3. N.H. Shah, M.T. Carvajal, and C.I. Patel Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs Int. J. Pharm. 106 1994 15 23
4. D.I. Burcham, M.B. Maurin, E.A. Hausner, and S.M. Huang Improved oral bioavailability of the hypocholestrolemic DMP 565 in dogs following oral dosing in oil and glycol solutions Biopharm. Drug Dispos. 18 1997 737 742
5. M. Sentjurc, K. Vrhovnik, and J. Kristl Liposomes as a topical delivery system: the role of size on transport by the EPR imaging method J. Control. Rel. 1 1999 87 97
6. G. Betageri, and M. Habib Liposomes as drug carriers Pharm. Eng. 14 1994 76 77
7. H. Schreier, and J. Bouwstra Liposomes and niosomes as topical drug carriers: dermal and transdermal drug delivery J. Contr. Rel. 30 1994 1 15
8. A.J. Baillie, A.T. Florence, L.R. Hume, G.T. Muirhead, and A. Rogerson The preparation and properties of niosomes-non-ionic surfactant vesicles J. Pharm. Pharmacol. 37 1985 863 868
9. C. Hu, and D.G. Rhodes Proniosomes: a novel drug carrier preparation Int. J. Pharm. 185 1999 23 35
10. A.I. Blazek-Welsh, and D.G. Rhodes Maltodextrin-based proniosomes AAPS Pharm. Sci. 3 2001 1 8
11. M. Nasr In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration AAPS Pharm. Sci. Tech. 11 2010 85 89
12. H.K. Ibrahim, and D.A. El-Setouhy Valsartan orodispersible tablets: formulation. In vitro/in vivo characterization AAPS Pharm. Sci. Tech. 11 2010 189 196
13. S. Rajput, A. Dixit, and S.G. Patel Preparation and bioavailability assessment of SMEDDS containing valsartan AAPS Pharm. Sci. Tech. 11 2010 314 321
14. A. Sharma, and C.P. Jain Preparation and characterization of solid dispersions of Valsartan with Poloxamer 188 Der. Pharm. Lett. 2 2010 54 63
15. A.B. Solanki, J.R. Parikh, and R.H. Parikh Formulation and optimization of piroxicam proniosomes by 3-factor, 3-level box-behnken design AAPS Pharm. Sci. Tech. 8 4 2007 E1 E7
16. J.N. Staniforth Pharmaceutics M.E. Aulton, The Science Dosage Form Design 1988 Churchill Livingstone 610 636
17. R.L. Carr Evaluation flow properties of solids Chem. Eng. 72 1965 163 168
18. J. Subheet, J. Parijat, R.B. Umamaheshwari, and N.K. Jain Transfersomes - A novel vesicular carrier for enhanced transdermal delivery: Development, characterization, and performance evaluation Drug Dev. Ind. Pharm. 29 2003 1013 1026
19. R. Jukanti, S. Sheela, S. Bandari, and P.R. Veerareddy Enhanced bioavailability of exemestane via proliposomes based transdermal delivery J.Pharm. Sci. 100 2011 3208 3222
20. T. Sevgi, and S. Serap Comparison of UV- and second derivative spectrophotometric and LC methods for the determination of valsartan in pharmaceutical formulation J. Pharm. Biomed. Anal. 30 2002 371 375
21. O.A. Sammour, M.A. Hammad, N.A. Megrab, and A.S. Zidan Formulation and optimization of mouth dissolving tablets containing rofecoxib solid dispersion AAPS Pharm. Sci. Tech. 7 2006 1 8
22. M. Valleri, P. Mura, F. Maeshrelli, M. Cirri, and R. Ballerini Development and evaluation of glyburide fast dissolving tablets using solid dispersion technique Drug Dev. Ind. Pharm. 30 2004 525 534
23. K.G. Pradip, J.M. Rita, L.U. Manish, and S.R.M. Rayasa Design and development of microemulsion drug delivery system of acyclovir for improvement of oral bioavailability AAPS Pharm. Sci. Tech. 7 2006 E1 E5
24. A.I. Blazek-Welsh, and D.G. Rhodes Maltodextrin-based proniosomes Pharm. Sci. 3 2001 1 8
25. A.I. Blazek-Welsh, and D.G. Rhodes SEM imaging predicts quality of niosomes from maltodextrin-based proniosomes Pharm. Res. 18 2001 656 661
26. A. Rogerson, J. Cummings, and A.T. Florence Adriamycin loaded niosomes: drug entrapment, stability and release J. Microencapsul. 4 1987 321 328
27. G. Gregoriadis Liposome Technology 2nd ed. 1993 CRC Press Boca Raton FL.
28. E. Touitou, H.E. Junginger, N.D. Weiner, T. Nagai, and M. Mezei Liposomes as carrier for topical and transdermal delivery J. Pharm. Sci. 83 1994 1189 1203
29. T. Ogiso, N. Niinaka, and M. Iwaki Mechanism for enhancement effect of lipid disperse system on percutaneous absorption J. Pharm. Sci. 85 1996 57 64
30. Y. Hao, F. Zhao, N. Li, Y. Yang, and K. Li Studies on a high encapsulation of colchicine by niosome system Int. J. Pharm. 244 2002 73 80
31. A.H. Kibbe Handbook of Pharmaceutical Excipients 3rd ed. 2000 American Pharmaceutical Association Washington, DC pp. 511-514
32. J. Varshosaz, A. Pardakhty, and M.H.B. Seied Sorbitan monopalmitate-based proniosomes for transdermal delivery of chlorpheniramine maleate Drug Deliv. 12 2005 75 82
33. J. Staniforth Powder flow M. Aulton, Pharmaceutics, The science of dosage form design, 2nd ed. Churchill Livingstone 2002 Longman Group Edinburgh 197 210
34. J. Plessis, C. Ramachandran, N. Weiner, and D.G. Miller The influence of particle size of liposomes on deposition of drug into skin Int. J. Pharm. 103 1991 277 282
35. D. Gopinath, D. Ravi, B.R. Rao, S.S. Apte, D. Renuka, and D. Rambhau Ascorbyl palmitate vesicles (Aspasomes): formation, characterization and applications Int. J. Pharm. 271 2004 95 113
36. A. Chandra, and P.K. Sharma Proniosome based drug delivery system of piroxicam Afr. J. Pharm. Pharmacol. 2 9 2008 184 190
37. C. Bernsdorff, A. Wolff, R. Winter, and E. Gratton Effect of hydrostatic pressure on water penetration and rotational dynamics in phospholipid- cholesterol bilayers Biophys. J. 72 1997 1264 1277
38. G. Cornaire, J. Woodley, P. Hermann, A. Cloarec, C. Arellano, and G. Houin Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo Int. J. Pharm. 278 2004 119 131